Ibere Pharmaceuticals
Shell Companies
Financial Services
IBER
13.80 M shares
NYSE US
traded
01 Mar 2023
listed
yes
open
10.18
52 week high
10.20
high
10.18
52 week low
9.62
previous Close
10.20
P/E ratio
market cap
170 M
div yield
0
net incoming
1.47 M
-58.77 %
net profit margin
147340300.00 %
0.00 %
operating incoming
-140.53 K
53.56 %
net change in cash
-41.71 K
87.11 %
cash on hand
93.04 K
-30.96 %
cost of revenue
141 K
-53.56 %
top